BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31464257)

  • 21. Siblings with Alport's syndrome showing unique staining patterns for alpha5(IV) and alpha6(IV) chains of collagen type IV.
    Tsuji T; Fujigaki Y; Sakakima M; Sado Y; Hishida A
    Clin Exp Nephrol; 2010 Jun; 14(3):283-7. PubMed ID: 20213338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
    Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
    J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport's syndrome.
    Wang F; Zhao D; Ding J; Zhang H; Zhang Y; Yu L; Xiao H; Yao Y; Zhong X; Wang S
    J Mol Diagn; 2012 Nov; 14(6):586-93. PubMed ID: 22921432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A splicing mutation in the alpha 5(IV) collagen gene of a family with Alport's syndrome.
    Nomura S; Osawa G; Sai T; Harano T; Harano K
    Kidney Int; 1993 May; 43(5):1116-24. PubMed ID: 8510391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alport's syndrome: new findings].
    García-Torres R; Orozco L
    Bol Med Hosp Infant Mex; 1993 Aug; 50(8):596-602. PubMed ID: 8357522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
    Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene symbol: COL4A5. Disease: Alport syndrome.
    Neri TM; Sebastio P
    Hum Genet; 2005 Dec; 118(3-4):543. PubMed ID: 16521290
    [No Abstract]   [Full Text] [Related]  

  • 28. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel COL4A3 gene mutations in a consanguineous family with autosomal recessive Alport syndrome.
    Sirisena ND; Thalgahagoda S; Abeyagunawardena A; Neumann M; Schmudlach HO; Jayasekara RW; Dissanayake VH
    Nephrology (Carlton); 2015 Aug; 20(8):580. PubMed ID: 26194984
    [No Abstract]   [Full Text] [Related]  

  • 31. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome.
    King K; Flinter FA; Green PM
    Hum Mutat; 2006 Oct; 27(10):1061. PubMed ID: 16941480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Injury by Variants in the
    Frese J; Kettwig M; Zappel H; Hofer J; Gröne HJ; Nagel M; Sunder-Plassmann G; Kain R; Neuweiler J; Gross O
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin.
    van der Loop FT; Monnens LA; Schröder CH; Lemmink HH; Breuning MH; Timmer ED; Smeets HJ
    Kidney Int; 1999 Apr; 55(4):1217-24. PubMed ID: 10200983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary diagnostic approach in Alport's syndrome.
    Grünfeld JP
    Ren Fail; 2000 Nov; 22(6):759-63. PubMed ID: 11104163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.
    Beicht S; Strobl-Wildemann G; Rath S; Wachter O; Alberer M; Kaminsky E; Weber LT; Hinrichsen T; Klein HG; Hoefele J
    Gene; 2013 Sep; 526(2):474-7. PubMed ID: 23732293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gene corresponding to the putative Goodpasture antigen is present in Alport's syndrome.
    Savige JA
    Clin Exp Immunol; 1991 Aug; 85(2):236-9. PubMed ID: 1864003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance.
    Pochet JM; Bobrie G; Landais P; Goldfarb B; Grünfeld JP
    Nephrol Dial Transplant; 1989; 4(12):1016-21. PubMed ID: 2517321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alport's syndrome: apropos of 2 families].
    Grünfeld JP
    Nephrologie; 2000; 21(6):295-8. PubMed ID: 11117109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular aspects of Alport's syndrome.
    Weber M; Netzer KO; Pullig O
    Clin Investig; 1992 Sep; 70(9):809-15. PubMed ID: 1450636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.